Mubadala Capital Partakes in USD 200 Million Investment into Tenvie Therapeutics

Mubadala Capital, based in the UAE, joins ARCH Venture Partners, F-Prime Capital, and others in a USD 200 million investment into Tenvie Therapeutics. This investment aims to accelerate Tenvie into a multi-clinical asset company. As...